Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 214

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth

Open access
Cabello, Christopher M., Bair, Warner B., Lamore, Sarah D., Ley, Stephanie, Bause, Alexandra S., Azimian, Sara, Wondrak, Georg T.·2009·Free Radical Biology and Medicine

Abstract

Redox dysregulation in cancer cells represents a chemical vulnerability that can be targeted by prooxidant redox intervention. Dietary constituents that contain an electrophilic Michael acceptor pharmacophore may therefore display promising chemopreventive and chemotherapeutic anti-cancer activity. Here, we demonstrate that the cinnamon-derived dietary Michael acceptor trans-cinnamic aldehyde (CA) impairs melanoma cell proliferation and tumor growth. Feasibility of therapeutic intervention using high doses of CA (120 mg/kg, p.o., q.d., 10 days) was demonstrated in a human A375 melanoma SCID-mouse xenograft model. Low micromolar concentrations (IC50 < 10 μM) of CA, but not closely related CA-derivatives devoid of Michael acceptor activity, suppressed proliferation of human metastatic melanoma cell lines (A375, G361, LOX) with G1 cell cycle arrest, elevated intracellular ROS, and impaired invasiveness. Expression array analysis revealed that CA induced an oxidative stress response in A375 cells, up-regulating heme oxygenase-1 (HMOX1), sulfiredoxin 1 homolog (SRXN1), thioredoxin reductase 1 (TXNRD1), and other genes including the cell cycle regulator and stress-responsive tumor suppressor gene cyclin-dependent kinase inhibitor 1A (CDKN1A), a key mediator of G1 phase arrest. CA, but not Michael-inactive derivatives, inhibited NFκB transcriptional activity and TNFα-induced IL-8 production in A375 cells. These findings support a previously unrecognized role of CA as a dietary Michael acceptor with potential anticancer activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.freeradbiomed.2008.10.025

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 50

  1. Lens, 2004, Global perspectives of contemporary epidemiological trends of cutaneous malignant melanoma, Br. J. Dermatol., 150, 179, 10.1111/j.1365-2133.2004.05708.x · DOI · Paper page
  2. Qin, 2004, p53-independent NOXA induction overcomes apoptotic resistance of malignant melanomas, Mol. Cancer Ther., 3, 895, 10.1158/1535-7163.895.3.8 · DOI
  3. Wondrak, 2005, An emerging molecular target in melanoma: cellular carbonyl stress and the inhibition of mitochondrial survival pathways by carbonyl scavenger agents, Curr. Cancer Ther. Rev., 1, 271, 10.2174/157339405774574234 · doi:10.2174/157339405774574234
  4. Meyskens, 2007, New perspectives on melanoma pathogenesis and chemoprevention, Recent Results Cancer Res., 174, 191, 10.1007/978-3-540-37696-5_16 · DOI
  5. Eberle, 2007, Overcoming apoptosis deficiency of melanoma—hope for new therapeutic approaches, Drug Resist. Update, 10, 218, 10.1016/j.drup.2007.09.001 · DOI
  6. Brar, 2001, Reactive oxygen species from NAD(P)H:quinone oxidoreductase constitutively activate NF-kappaB in malignant melanoma cells, Am. J. Physiol. Cell Physiol., 280, C659, 10.1152/ajpcell.2001.280.3.C659 · DOI
  7. Govindarajan, 2007, Overexpression of Akt converts radial growth melanoma to vertical growth melanoma, J. Clin. Invest., 117, 719, 10.1172/JCI30102 · DOI · Paper page
  8. Fruehauf, 2007, Reactive oxygen species: a breath of life or death?, Clin. Cancer Res., 13, 789, 10.1158/1078-0432.CCR-06-2082 · DOI · Paper page
  9. Fried, 2008, The reactive oxygen-driven tumor: relevance to melanoma, Pigment Cell Melanoma Res., 21, 117, 10.1111/j.1755-148X.2008.00451.x · DOI
  10. Brar, 2002, An NAD(P)H oxidase regulates growth and transcription in melanoma cells, Am. J. Physiol. Cell Physiol., 282, C1212, 10.1152/ajpcell.00496.2001 · DOI · Paper page
  11. Engel, 2006, Oxidative stress and apoptosis: a new treatment paradigm in cancer, Front. Biosci., 11, 300, 10.2741/1798 · DOI · Paper page
  12. Cabello, 2007, Experimental therapeutics: targeting the redox Achilles heel of cancer, Curr. Opin. Invest. Drugs, 8, 1022
  13. Cen, 2004, Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells, J. Med. Chem., 47, 6914, 10.1021/jm049568z · DOI · Paper page
  14. Wondrak, 2007, NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis, Free Radic. Biol. Med., 43, 178, 10.1016/j.freeradbiomed.2007.03.035 · DOI
  15. Loewe, 2006, Dimethylfumarate impairs melanoma growth and metastasis, Cancer Res., 66, 11888, 10.1158/0008-5472.CAN-06-2397 · DOI
  16. Wang, 2008, Plumbagin induces cell cycle arrest and apoptosis through reactive oxygen species/c-Jun N-terminal kinase pathways in human melanoma A375.S2 cells, Cancer Lett., 259, 82, 10.1016/j.canlet.2007.10.005 · DOI · Paper page
  17. Magda, 2006, Motexafin gadolinium: a novel redox active drug for cancer therapy, Semin. Cancer Biol., 16, 466, 10.1016/j.semcancer.2006.09.002 · DOI · Paper page
  18. Tuma, 2008, Reactive oxygen species may have antitumor activity in metastatic melanoma, J. Natl. Cancer Inst., 100, 11, 10.1093/jnci/djm299 · DOI
  19. Esterbauer, 1991, Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radic. Biol. Med., 11, 81, 10.1016/0891-5849(91)90192-6 · DOI · Paper page
  20. Kurtz, 2003, 1,N2-deoxyguanosine adducts of acrolein, crotonaldehyde, and trans-4-hydroxynonenal cross-link to peptides via Schiff base linkage, J. Biol. Chem., 278, 5970, 10.1074/jbc.M212012200 · DOI
  21. O'Brien, 2005, Aldehyde sources, metabolism, molecular toxicity mechanisms, and possible effects on human health, Crit. Rev. Toxicol., 35, 609, 10.1080/10408440591002183 · DOI · Paper page
  22. Chan, 2008, Application of structure- activity relationships to investigate the molecular mechanisms of hepatocyte toxicity and electrophilic reactivity of alpha,beta- unsaturated aldehydes, J. Appl. Toxicol., 28, 1027, 10.1002/jat.1369 · DOI
  23. Friedman, 2000, Cinnamaldehyde content in foods determined by gas chromatography–mass spectrometry, J. Agric. Food Chem., 48, 5702, 10.1021/jf000585g · DOI · Paper page
  24. Peters, 1994, Studies on trans-cinnamaldehyde. 1. The influence of dose size and sex on its disposition in the rat and mouse, Food Chem. Toxicol., 32, 869, 10.1016/0278-6915(94)90084-1 · doi:10.1016/0278-6915(94)90084-1
  25. Wu, 2006, Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein, Toxicol. Appl. Pharmacol., 214, 244, 10.1016/j.taap.2005.12.013 · DOI
  26. Singh, 2007, A comparison of chemical, antioxidant and antimicrobial studies of cinnamon leaf and bark volatile oils, oleoresins and their constituents, Food Chem. Toxicol., 45, 1650, 10.1016/j.fct.2007.02.031 · DOI · Paper page
  27. Matan, 2006, Antimicrobial activity of cinnamon and clove oils under modified atmosphere conditions, Int. J. Food Microbiol., 107, 180, 10.1016/j.ijfoodmicro.2005.07.007 · DOI · Paper page
  28. Kurokawa, 1998, Antipyretic activity of cinnamyl derivatives and related compounds in influenza virus-infected mice, Eur. J. Pharmacol., 348, 45, 10.1016/S0014-2999(98)00121-6 · DOI
  29. Kim, 2007, Suppression of age-related inflammatory NF-kappaB activation by cinnamaldehyde, Biogerontology, 8, 545, 10.1007/s10522-007-9098-2 · DOI
  30. Wondrak, 2008, Cinnamoyl-based Nrf2-activators targeting human skin cell photo-oxidative stress, Free Radic. Biol. Med., 45, 385, 10.1016/j.freeradbiomed.2008.04.023 · DOI
  31. Wondrak, 2006, Antimelanoma activity of apoptogenic carbonyl scavengers, J. Pharmacol. Exp. Ther., 316, 805, 10.1124/jpet.105.094953 · DOI
  32. Pani, 2002, Determination of intracellular reactive oxygen species as function of cell density, Methods Enzymol., 352, 91, 10.1016/S0076-6879(02)52010-3 · doi:10.1016/s0076-6879(02)52010-3
  33. Jenner, 1964, Food flavourings and compounds of related structure. I. Acute oral toxicity, Food Cosmet. Toxicol., 2, 327, 10.1016/S0015-6264(64)80192-9 · DOI · Paper page
  34. Cortese, 2008, Zinc protects endothelial cells from hydrogen peroxide via Nrf2-dependent stimulation of glutathione biosynthesis, Free Radic. Biol. Med., 44, 2002, 10.1016/j.freeradbiomed.2008.02.013 · DOI · Paper page
  35. Liao, 2008, Cinnamaldehyde inhibits the tumor necrosis factor-alpha-induced expression of cell adhesion molecules in endothelial cells by suppressing NF-kappaB activation: effects upon IkappaB and Nrf2, Toxicol. Appl. Pharmacol., 229, 161, 10.1016/j.taap.2008.01.021 · DOI
  36. Ueda, 2006, NF-kappaB activation in melanoma, Pigment Cell Res., 19, 112, 10.1111/j.1600-0749.2006.00304.x · DOI · Paper page
  37. Iersel, 1996, Inhibition of glutathione S-transferase activity in human melanoma cells by α, βunsaturated carbonyl derivatives: effects of acrolein, cinnamaldehyde, citral, crotonaldehyde, curcumin, ethacrynic acid, and trans-2-hexenal, Chem. Biol. Interact., 102, 117, 10.1016/S0009-2797(96)03739-8 · DOI
  38. Siwak, 2005, Cancer, 104, 879, 10.1002/cncr.21216 · DOI · Paper page
  39. Rozenblat, 2008, Induction of G2/M arrest and apoptosis by sesquiterpene lactones in human melanoma cell lines, Biochem. Pharmacol., 75, 369, 10.1016/j.bcp.2007.08.024 · DOI
  40. Han, 2008, The in vivo gene expression signature of oxidative stress, Physiol. Genomics, 34, 112, 10.1152/physiolgenomics.00239.2007 · DOI · Paper page
  41. O'Reilly, 2005, Redox activation of p21Cip1/WAF1/Sdi1: a multifunctional regulator of cell survival and death, Antioxid. Redox Signal., 7, 108, 10.1089/ars.2005.7.108 · DOI
  42. Shen, 2006, p53-independent G1 cell cycle arrest of human colon carcinoma cells HT-29 by sulforaphane is associated with induction of p21CIP1 and inhibition of expression of cyclin D1, Cancer Chemother. Pharmacol., 57, 317, 10.1007/s00280-005-0050-3 · DOI
  43. Maytin, 2001, Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and-independent mechanisms, Exp. Cell Res., 267, 193, 10.1006/excr.2001.5248 · DOI · Paper page
  44. Wen, 2002, Oxidative stress-mediated apoptosis: the anticancer effect of the sesquiterpene lactone parthenolide, J. Biol. Chem., 277, 38954, 10.1074/jbc.M203842200 · DOI · Paper page
  45. Stuart, 2005, c-Abl regulates early growth response protein (EGR1) in response to oxidative stress, Oncogene, 24, 8085, 10.1038/sj.onc.1208953 · doi:10.1038/sj.onc.1208953
  46. Gibbs, 2008, Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia, Oncogene, 27, 98, 10.1038/sj.onc.1210627 · DOI
  47. Reddy, 2004, Cinnamaldehyde and 2-methoxycinnamaldehyde as NF-kappaB inhibitors from Cinnamomum cassia, Planta Med., 70, 823, 10.1055/s-2004-827230 · DOI
  48. Singh, 1999, Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin, Melanoma Res., 9, 383, 10.1097/00008390-199908000-00007 · DOI
  49. Schaider, 2003, Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8, Int. J. Cancer, 103, 335, 10.1002/ijc.10775 · DOI · Paper page
  50. Leslie, 2005, Regulation of gene expression in melanoma: new approaches for treatment, J. Cell. Biochem., 94, 25, 10.1002/jcb.20296 · DOI

Cited by

See all 214

Metadata

Authors
Cabello, C. M., Bair, W. B., Lamore, S. D., Ley, S., Bause, A. S., Azimian, S., & Wondrak, G. T.
Venue
Free Radical Biology and Medicine
Publisher
Elsevier BV
Published
2009-01
Volume
46
Issue
2
Pages
220-231
ISSN
0891-5849 (ISSN-L)
OpenAlex
W2020483122
Cited by
214
References
2
FWCI
2.23
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. https://app.cochat.ai/papers/10.1016/j.freeradbiomed.2008.10.025
The paper
Cabello, C. M., Bair, W. B., Lamore, S. D., Ley, S., Bause, A. S., Azimian, S., & Wondrak, G. T. (2009). The cinnamon-derived Michael acceptor cinnamic aldehyde impairs melanoma cell proliferation, invasiveness, and tumor growth. Free Radical Biology and Medicine. https://doi.org/10.1016/j.freeradbiomed.2008.10.025

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.